Clinica Baviera SA (CBAV.MC) Quote| Reuters.com
Edition:
United States

Clinica Baviera SA (CBAV.MC)

CBAV.MC on Madrid SE C.A.T.S.

6.24EUR
27 Jun 2016
Change (% chg)

-- (--)
Prev Close
€6.24
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
6,822
52-wk High
€7.57
52-wk Low
€4.40

CBAV.MC

Chart for CBAV.MC

About

Clinica Baviera SA is a Spain-based company primarily engaged in the provision of all types of services within the field of ophthalmic medicine. The Company is specialized in the diagnosis and treatment of eye disorders such as myopia, hyperopia, astigmatism, cataracts, glaucoma, vitreus-retina and strabismus, among others. The... (more)

Overall

Beta: 0.73
Market Cap(Mil.): €101.76
Shares Outstanding(Mil.): 16.31
Dividend: 0.15
Yield (%): 3.85

Financials

  CBAV.MC Industry Sector
P/E (TTM): 15.91 54.72 34.11
EPS (TTM): 0.39 -- --
ROI: -- 5.50 14.23
ROE: -- 8.71 15.46

BRIEF-Clinica Baviera Q1 revenue up 12 percent vs year ago

* Q1 net profit 2.9 million euros ($3.3 million) versus 1.4 million euros year ago

May 12 2016

BRIEF-Clinica Baviera to propose dividend of 0.15 euro gross/ shr

* Says to propose dividend of 0.15 euro ($0.1713) gross per share, which will be paid on June 7 Source text for Eikon: Further company coverage: ($1 = 0.8755 euros) (Gdynia Newsroom)

Apr 01 2016

BRIEF-Clinica Baviera H2 net profit up at 2.9 mln euros

* H2 net sales 43.3 million euros ($47.8 million)versus 41.1 million euros year ago

Feb 25 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Reuters Investment Profile
$20.00
Provider : Wright Reports
$75.00
Provider : GlobalData
$125.00
Provider : GlobalData
$125.00
Provider : GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.